The following Life Sciences practice note provides comprehensive and up to date legal information covering:
This Practice Note tracks the developments and updates on coronavirus (COVID-19) that relate to the life sciences sector.
Research and development of medicines and vaccines
Regulation of medical devices
Regulation of medicinal products and blood
Supply of medicines and medical products
Actions on falsified and unlicensed medicines, off-label use of medical devices
mHealth and data protection
For a discussion on:
the impact of the coronavirus pandemic on the UK and EU regulatory frameworks, see Practice Note: Coronavirus (COVID-19)—regulatory implications for the UK and European life sciences industry
what life sciences companies should take into account when protecting and sharing intellectual property (IP) with third parties in the fight against the coronavirus pandemic in order to avoid potentially adverse unintended consequences, see Practice Note: Coronavirus (COVID-19)—intellectual property implications for life sciences companies
a vision of the future for life sciences industry after the coronavirus pandemic, see News Analysis: A vision of the future after Coronavirus (COVID-19)
the use of artificial intelligence (AI) by researchers, governments and health organisations as a tool to bolster the fight against the coronavirus, see News Analysis: Artificial Intelligence in the fight against coronavirus (COVID-19)
the role of wearables in the battle against coronavirus, see News Analysis: COVID-19 and Digital Health: the role of wearables in the battle against COVID-19
a new type of vaccine, called mRNA, see News
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
This Practice Note considers the nature and scope of arbitration agreements with a particular focus on arbitration agreements pursuant to the law of England and Wales, although it also discusses the concept from an international perspective and includes some comparative examples from other
Tipping off and prejudicing an investigationIt would undermine the benefit to the authorities if, a suspicious activity report (SAR) having been made, the alleged offender were to be made aware of the interest in their activities so that they could take steps to cover up their misdeeds or disappear.
LiabilityFalse imprisonment consists of the complete deprivation of liberty without a lawful basis. Claims will in practice be made against a public body that exercises detention powers, usually a local police force, the Secretary of State for the Home Department or the Secretary of State for
Having established that a duty of care exists (see Practice Note: Negligence—when does a duty of care arise?), it is then necessary to consider whether or not there has been a breach of that duty. This will depend on a number of factors outlined below and considered against the general background of
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.